CARE Ratings Ratios

CARE Ratings Ltd Ratios

The CARE Ratings Ltd Ratios page provides a complete fundamental analysis of CARE Ratings Ltd using key valuation, profitability, and financial strength metrics. Investors tracking CARE Ratings Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

CARE Ratings Ltd (NSE: CARERATING, BSE: 534804) is currently trading at ₹1612.30, with a market capitalization of ₹48.3B. As a major player in the Commercial services sector and Financial publishing/Services industry, CARE Ratings Ltd remains a key stock for fundamental analysis using CARE Ratings Ltd Ratios.

CARE Ratings Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The CARE Ratings Ltd P/E ratio currently stands at 24.09, making it one of the most tracked metrics in CARE Ratings Ltd Ratios.

Historically, the CARE Ratings Ltd P/E ratio has shown strong fluctuations:

• 2024: 24.09
• 2023: 33.18
• 2022: 22.82
• 2021: 20.23
• 2020: 13.56

The decline in CARE Ratings Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The CARE Ratings Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 4.09.

Historical P/B trend:

• 2024: 4.09
• 2023: 4.65
• 2022: 2.84
• 2021: 2.34

CARE Ratings Ltd is trading at a premium to its book value, indicating strong market confidence.

Price to Sales Ratio (P/S)

The CARE Ratings Ltd P/S ratio currently stands at 8.22, an important part of CARE Ratings Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 8.22
• 2023: 10.06
• 2022: 6.83
• 2021: 6.14

A stable or declining CARE Ratings Ltd P/S ratio indicates cautious market sentiment.

CARE Ratings Ltd Price to Cash Flow Ratio (P/CF)

The CARE Ratings Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 19.32.

Historical CARE Ratings Ltd Price to Cash Flow Ratio:

• 2024: 19.32
• 2023: 25.49
• 2022: 18.88
• 2021: 16.32
• 2020: 11.79

The declining CARE Ratings Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

CARE Ratings Ltd Enterprise Value Ratios

Enterprise Value (EV)

The CARE Ratings Ltd EV currently stands at ₹27.08B, representing the total company valuation including debt.

Historical EV trend:

• 2024: 27.08B
• 2023: 27.48B
• 2022: 13.81B
• 2021: 10.29B

CARE Ratings Ltd enterprise value consolidation suggests stable valuation.

EV/EBITDA Ratio

The CARE Ratings Ltd EV/EBITDA ratio is currently 17.13, a key metric in CARE Ratings Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 17.13
• 2023: 24.01
• 2022: 12.91
• 2021: 12.52

Stable CARE Ratings Ltd EV/EBITDA indicates balanced valuation.

CARE Ratings Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The CARE Ratings Ltd D/E ratio is currently 0.03, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0.03
• 2023: 0.03
• 2022: 0.03
• 2021: 0.01

CARE Ratings Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The CARE Ratings Ltd ROE currently stands at 18.02%, showing profitability and capital efficiency.

Historical ROE:

• 2024: 18.02
• 2023: 14.47
• 2022: 12.66
• 2021: 12.15

CARE Ratings Ltd maintains stable profitability levels.

CARE Ratings Ltd Ratios Analysis Summary

The CARE Ratings Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether CARE Ratings Ltd stock is undervalued, fairly valued, or overvalued.

Tracking CARE Ratings Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.